Dis-Chem reports record revenue as it beds down new acquisitions
The group’s acquisitions helped it grow revenue to above R30bn in 2022 for the first time in its history
23 May 2022 - 10:02
UPDATED 23 May 2022 - 13:24
Pharmacy group Dis-Chem says its recent string of acquisitions helped its revenue exceed R30bn for the first time in its history in its 2022 financial year, and it is optimistic about both a normalisation of shopping habits and better-than-expected uptake of its new health insurance offerings.
Dis-Chem’s health and personal care focus means it remains in the resilient part of the consumer retail market, CFO Rui Morais told Business Day, and the group is encouraged by returning footfall at larger malls, which consumers had avoided during the pandemic...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.